Barclays’s UpHealth, Inc. UPH Stock Holding History

Barclays’s Portfolio UPH Stock Details UPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-74	Closed	-$139	–	4826
2023 Q2	$139	Buy	74 +57	+335%	+$94	﹤0.01%	4430
2023 Q1	$25	Buy	+17	New	+$38	﹤0.01%	5023

Other funds holding UPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

KACA

Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MAMNY

Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Barclays's UPH Position: Q3 2023 in Review

Barclays sold out of UpHealth, Inc. (UPH) in Q3 2023, closing a stake of 74 shares — an estimated $139 sold.

Barclays first reported a position in UPH in Q1 2023 and held it in 2 quarters. The position peaked at $139 in Q2 2023. 33 funds tracked by Wall St. Rank hold UPH as of Q3 2023.

Barclays reported no remaining UpHealth, Inc. position as of Q3 2023 after selling out during the quarter.
Barclays sold 74 UpHealth, Inc. shares in Q3 2023, an estimated $139.
Barclays first reported a position in UpHealth, Inc. in Q1 2023 and held it in 2 quarters.
Barclays's UpHealth, Inc. position peaked at $139 in Q2 2023.
33 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.